News or Blog Viewer

Louisiana Department of Hospital Launches Hepatitis C Elimination Program

By Sylvia Guidry-Brown, MSN, APRN, FNP-BC, CSN posted 07-19-2019 15:43

  
Message Urgency: High

This is a message from the Louisiana Department of Health Emergency Operations Center (LDH EOC) to share a Health Advisory alerting clinicians to participate in a webinar to outline the Louisiana Hepatitis C Elimination Program. Please share and distribute with relevant stakeholders and partners through your own distribution channels.

On June 26th, Louisiana announced the launch of the Hepatitis C Elimination Program and the formal establishment of the first-in-the-nation hepatitis C modified subscription model. We are thrilled to share that the Hepatitis C Elimination Program officially went live across the state on July 15th.

Under the agreement, the Louisiana Departments of Health and Corrections have entered into a five-year contract with Asegua Therapeutics to provide unrestricted access to its authorized generic of Epclusa (sofosbuvir/velpatisvir) for treatment of hepatitis C among Medicaid beneficiaries and incarcerated patients. Generic Epclusa is effective against all known hepatitis C genotypes and is safe for patients with advanced fibrosis and/or cirrhosis.

The Louisiana Department of Health aims to diagnose 90 percent of individuals living with chronic hepatitis C and cure 80 percent of them. We want all of you to join in this elimination effort by screening the populations you serve and treating all eligible individuals living with hepatitis C.

The Louisiana Department of Health stands ready to help you. We ask that you please join us on July 25, 2019 at 12:00 noon for a one-hour webinar for providers entitled & ldquoLouisiana’s Hepatitis C Elimination Program: Streamlining Testing and Treatment.” During this call we will review the Hepatitis C Elimination Program and a streamlined test and treat algorithm which will eliminate elements of the existing care model that are unnecessary with a single therapy, one pill/once-a-day for twelve weeks regimen.

Please join us at 12 noon on Thursday, July 25, 2019 for a one-hour webinar for providers to highlight the streamlined testing and treatment protocols for the Hep C elimination program.
To join from PC, Mac, Linux, iOS or Android, click the link: https://zoom.us/j/113713012
If you must join by phone, we kindly ask that you please use the &ldquocall me” feature.
LDH EOC
0 comments
5 views

Permalink